1osenLS, Gordon D, Tchekmedyian S, et al.Zoledronic acid versus placebo in thetr5eatment of skeletal lmetastases in patientswith lung cancer and other solid tumors:aphase, double - blind, randomized trial - the Zoledronic acid lung cancer and other solid tumors study group = J >. J Clin Oneol,2003; 21(16) :3150 -3157.
3Rosen C J, Kessenich CR. Comparative pharmacology and therapeutic use of phonates in metabolic bone diseases. clinical bisphos- Drugs, 1996;51:537 -551.
4BerensonJR, HillnerBE, Kyle RA, et al. Ameri- can society of clinical oncology clinical practice guidelines: the role of bisphosphonates in multi- ple my eloma. JClin Oncol, 2002 ; 20 ( 17 ) : 3719 - 3736.
